Meridian Investment Counsel’s ImmunityBio IBRX Stock Holding History

Meridian Investment Counsel’s Portfolio IBRX Stock Details IBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$844K	Hold	96,433	–	–	0.18%	127
2026 Q1	$740K	Hold	96,433	–	–	0.18%	127
2025 Q4	$191K	Hold	96,433	–	–	0.05%	235
2025 Q3	$237K	Hold	96,433	–	–	0.06%	210
2025 Q2	$255K	Hold	96,433	–	–	0.07%	205
2025 Q1	$290K	Hold	96,433	–	–	0.09%	182
2024 Q4	$247K	Hold	96,433	–	–	0.07%	197
2024 Q3	$359K	Hold	96,433	–	–	0.11%	158
2024 Q2	$609K	Hold	96,433	–	–	0.19%	119
2024 Q1	$518K	Hold	96,433	–	–	0.17%	129
2023 Q4	$484K	Hold	96,433	–	–	0.17%	133
2023 Q3	$163K	Hold	96,433	–	–	0.06%	195
2023 Q2	$268K	Hold	96,433	–	–	0.1%	181
2023 Q1	$176K	Hold	96,433	–	–	0.07%	196
2022 Q4	$489K	Hold	96,433	–	–	0.2%	119
2022 Q3	$479K	Hold	96,433	–	–	0.21%	114
2022 Q2	$359K	Hold	96,433	–	–	0.15%	144
2022 Q1	$541K	Hold	96,433	–	–	0.19%	118
2021 Q4	$586K	Hold	96,433	–	–	0.19%	115
2021 Q3	$939K	Hold	96,433	–	–	0.34%	83
2021 Q2	$1.38M	Hold	96,433	–	–	0.49%	61
2021 Q1	$2.29M	Hold	96,433	–	–	0.88%	32
2020 Q4	$1.28M	Hold	96,433	–	–	0.54%	51
2020 Q3	$669K	Hold	96,433	–	–	0.32%	76
2020 Q2	$1.18M	Buy	+96,433	New	+$544K	0.6%	48

Other funds holding IBRX

SAM

SEB Asset Management Stockholm $26.6B AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

CCA

Clearwater Capital Advisors Hoffman Estates, Illinois $1.36B AUM 18.79% 1-Year Est. Return

Allen Holding New York $1.01B AUM 14.43% 1-Year Est. Return

Kercheville Advisors San Antonio, Texas $328M AUM 76.85% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

SSWM

Sheets Smith Wealth Management Winston-Salem, North Carolina $1B AUM 29.77% 1-Year Est. Return

LCGC

Legacy Capital Group California Los Gatos, California $332M AUM 42.15% 1-Year Est. Return

Meridian Investment Counsel's IBRX Position: Q2 2026 in Review

Meridian Investment Counsel held its ImmunityBio (IBRX) position steady in Q2 2026 at 96,433 shares worth $844K. The position accounts for 0.18% of the portfolio, ranked #127.

Meridian Investment Counsel first reported a position in IBRX in Q2 2020 and has held it in 25 quarters since. The position peaked at $2.29M in Q1 2021. 188 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

Meridian Investment Counsel held 96,433 shares of ImmunityBio worth $844K as of Q2 2026.
Meridian Investment Counsel left its ImmunityBio share count unchanged in Q2 2026.
ImmunityBio made up 0.18% of Meridian Investment Counsel's portfolio in Q2 2026, its #127 holding.
Meridian Investment Counsel first reported a position in ImmunityBio in Q2 2020 and has held it in 25 quarters since.
Meridian Investment Counsel's ImmunityBio position peaked at $2.29M in Q1 2021.
188 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Meridian Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.